Koāte-DVI Efficacy

A proven treatment for classical hemophilia A patients1,2

  • Koate-DVI demonstrates a mean biologic half-life of 16.12 hours
  • Is effective in a single dose*
  • Well-tolerated with a low risk (0.7%) of adverse events1

*A total of 306 bleeding episodes were treated in one study, of which 82% were treated adequately with a single infusion of Koate-DVI.

 

References: 1. Koate-DVI [prescribing information]. Fort Lee, NJ: Kedrion Biopharma Inc., 2012. 2. Powell JS, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson AR, Hurst D. Safety and efficacy of solvent/detergent- treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000;6(3):140-9.